Baron Global Advantage Fund advanced during the fourth quarter of 2024, outperforming its benchmark, the MSCI ACWI Index.

Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and ...